oral vs subcutaneous semaglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Frontiers | Comparative analysis of
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7


























![Original 151 Complete Set (151/150) 1999 [MP-DMG]](https://tradingcardsets.com/cdn/shop/products/image_a0e68749-14e9-4c80-9dd1-16b219222261_436x436.heic?v=1685228698)


